MyHeritage Establishes Scientific Advisory Board to Support the Expansion of its DNA Product Line

Experts in genomics and biotechnology will advise MyHeritage on its plans to expand its DNA offerings into additional domains, including health and wellness

Advisory Board Final
Advisory Board Final
orange mh logo
orange mh logo

TEL AVIV, Israel & LEHI, Utah–(BUSINESS WIRE)–#WholeGenomeSequencing—MyHeritage, the leading global platform for family history and DNA testing, announced today the establishment of a Scientific Advisory Board of experts in genomics, biotechnology, and related fields. The board’s founding members are Yaniv Erlich, PhD, Daniel Kraft, MD, and Jamie Metzl, PhD.

The board will advise MyHeritage as the company expands its DNA offerings into additional domains, including health and wellness, to ensure that its new products have robust scientific foundations. MyHeritage DNA — MyHeritage’s flagship at-home DNA test for genetic genealogy, and the first in the industry to use Whole Genome Sequencing, will remain at the core of the company’s DNA product line.

“We’re delighted to have Dr. Yaniv Erlich, Dr. Daniel Kraft, and Dr. Jamie Metzl join as founding members of our Scientific Advisory Board,” said Ido Eytan, General Manager of Health, Wellness & New Initiatives at MyHeritage. “As we expand our DNA offerings, we place special focus on developing products based on rigorous scientific evidence. We look forward to working with Yaniv, Daniel, and Jamie to bring to market a new generation of unique products that benefit from MyHeritage’s global expertise in consumer genetics.”

The establishment of the board also marks the return of Dr. Yaniv Erlich to MyHeritage, this time as an advisor. As the company’s former Chief Science Officer, Dr. Erlich played a key role in the scientific research and development of the MyHeritage DNA test.

The Scientific Advisory Board brings together three leaders in genomics and healthcare technology:

  • Yaniv Erlich, PhD: DNA scientist and biotechnology entrepreneur whose research in computational biology and genomics has been published in leading journals including Nature and Science; Co-Founder of ScionxBio; and Co-Founder and CEO of Undecimal Bio. Formerly a professor in Columbia University, he has been dubbed the “Genome Hacker”.
  • Daniel Kraft, MD: Stanford and Harvard-trained physician-scientist focused on the future of health and medicine, Adjunct Professor at Stanford University School of Medicine, founder of NextMed Health, and founding Chair of Medicine at Singularity University.
  • Jamie Metzl, PhD: Author of Hacking Darwin and Superconvergence; former member, WHO Expert Advisory Committee on Human Genome Editing, advisory board member, Harvard Medical School Preventive Genomics and Lake Nona Impact Forum.

About MyHeritage

MyHeritage is the leading global platform for family history and DNA testing. It enriches the lives of people worldwide by enabling them to discover more about their family’s past and to empower their future. MyHeritage is home to one of the world’s largest consumer DNA databases, with over 10 million customers, and is the most popular DNA test in Europe. With a suite of intuitive, AI-powered products, MyHeritage provides a deeply rewarding experience that is enjoyed by tens of millions of people around the world. MyHeritage offers full privacy controls and is available in 50 languages. www.myheritage.com

Contacts

MyHeritage

Margaux Stelman

Head of Public Relations

Phone: +972 52-953-4295

Email: [email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.